1. Home
  2. PHAR vs CCNE Comparison

PHAR vs CCNE Comparison

Compare PHAR & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • CCNE
  • Stock Information
  • Founded
  • PHAR 1988
  • CCNE 1865
  • Country
  • PHAR Netherlands
  • CCNE United States
  • Employees
  • PHAR N/A
  • CCNE N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • CCNE Major Banks
  • Sector
  • PHAR Health Care
  • CCNE Finance
  • Exchange
  • PHAR Nasdaq
  • CCNE Nasdaq
  • Market Cap
  • PHAR 627.5M
  • CCNE 595.8M
  • IPO Year
  • PHAR N/A
  • CCNE N/A
  • Fundamental
  • Price
  • PHAR $8.58
  • CCNE $26.84
  • Analyst Decision
  • PHAR Strong Buy
  • CCNE Hold
  • Analyst Count
  • PHAR 3
  • CCNE 1
  • Target Price
  • PHAR $27.00
  • CCNE $30.00
  • AVG Volume (30 Days)
  • PHAR 7.3K
  • CCNE 46.5K
  • Earning Date
  • PHAR 10-24-2024
  • CCNE 01-21-2025
  • Dividend Yield
  • PHAR N/A
  • CCNE 2.59%
  • EPS Growth
  • PHAR N/A
  • CCNE N/A
  • EPS
  • PHAR N/A
  • CCNE 2.33
  • Revenue
  • PHAR $285,745,000.00
  • CCNE $216,515,000.00
  • Revenue This Year
  • PHAR $20.89
  • CCNE N/A
  • Revenue Next Year
  • PHAR $11.15
  • CCNE $8.80
  • P/E Ratio
  • PHAR N/A
  • CCNE $11.53
  • Revenue Growth
  • PHAR 30.64
  • CCNE N/A
  • 52 Week Low
  • PHAR $6.65
  • CCNE $17.74
  • 52 Week High
  • PHAR $13.20
  • CCNE $29.29
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 53.32
  • CCNE 48.49
  • Support Level
  • PHAR $8.71
  • CCNE $27.00
  • Resistance Level
  • PHAR $9.59
  • CCNE $27.67
  • Average True Range (ATR)
  • PHAR 0.33
  • CCNE 0.59
  • MACD
  • PHAR 0.11
  • CCNE -0.18
  • Stochastic Oscillator
  • PHAR 51.03
  • CCNE 25.00

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. In addition, the corporation provides wealth and asset management services, retirement plans and other employee benefit plans.

Share on Social Networks: